Company & Sponsor Intelligence

Tongji Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials7
Recruiting4
Completed1
Countries1

Therapeutic footprint

autismmigraine_headachemultiple_sclerosisneuroimmunologyother_psychiatryparkinsons

Indexed studies

NCT06474520Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)
multiple_sclerosis · China
NA
NCT05531669Effect of PLAY Project Intervention Program on Children With ASD
autism · China
NA
NCT06980064Wearable Devices Assist in the Detection, Screening, and Management of Major Diseases in Middle-aged and Elderly Populations
parkinsons ·
NA
NCT07269561Headache Registration and Followup Initiated by Tongji Hospital, HUST
migraine_headache · China
RECRUITING
NCT06584045Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)
neuroimmunology · China
NA
NCT04948814Application of Fecal Microbiota Transplantation in Children With ASD
autism · China
PHASE1
NCT06748391Nitric Oxide Levels Were Associated With Postoperative Delirium Following Cardiac Surgery
other_psychiatry · China
COMPLETED

Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →